Interaction Between ABT-335, Rosuvastatin and Warfarin

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

This is a multiple-dose, double-blind, randomized, single-center, parallel-group study in adult male subjects in general good health.

Key facts

Study ID

NCT00487136

Run by

AstraZeneca

People needed

45

Starts

2007-06-01

Expected to finish

2007-07-01

Last updated by the study team

2012-09-28

Who can join

Age: 18 and older, up to 50. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Body mass index (BMI) is 19 to 29, inclusive.
• A condition of general good health, based upon the results of a medical history, physical examination, vital signs, laboratory profile and a 12-lead electrocardiogram (ECG).
• Written informed consent prior to the initiation of screening or study-specific procedures.

You may not qualify if…

• Subjects with unstable medical conditions or medical conditions considered inappropriate in a clinical trial.
• Subjects taking concomitant medications.
• Subjects with a recent history of surgery or trauma.
• Subjects with a history of any bleeding disorder.

Where it is running

• Site Ref # / Investigator 5290 — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.